| 231 |
ISADX |
IXAZOMIB 4 MG |
CAPSULE |
BOTTLE |
USED IN COMBINATION WITH LENALIDOMIDE AND DEXAMETHASONE TO TREAT MULTIPLE MYELOMA (CANCER OF PLASMA CELLS IN THE BONE MARROW) THAT HAS WORSENED AFTER TREATMENT WITH OTHER CHEMOTHERAPY MEDICATION |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
08 L 1006/23 |
21-AUG-2023 |
20-AUG-2026 |
View |
| 232 |
KESODX |
CRIZOTINIB 250 MG |
CAPSULE |
BOTTLE |
TREATMENT OF PATIENTS WITH MATASTATIC NON SMALL CELL LUNG CANCER WHOSE TUMORS ARE ANAPLASTIC LYMPHOMA KINASE OR ROS1-POSITIVE |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
08 L 1171/24 |
22-AUG-2024 |
21-AUG-2027 |
View |
| 233 |
KOBIDX |
COBIMETINIB 20 MG |
FILM COATED TABLET |
BOTTLE |
for the treatment of unresectable or metastatic melanoma with a BRAF V600E or V600K mutation |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
05 L 1352/25 |
27-MAY-2025 |
26-MAY-2030 |
View |
| 234 |
LARODX |
LAROTRECTINIB 100 MG |
CAPSULE |
BOTTLE |
TO TREAT A CERTAIN TYPE OF SOLID TUMORS IN ADULT, CHILDREN AND INFANT 4 WEEKS OF AGE AND OLDER THAT HAVE SPREAD TO PTHER PATRS OF THE BODY OR CANNOT BE TREATED SUCCESSFULLY WITH SURGERY |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
04 L 1086/24 |
08-APR-2024 |
07-APR-2027 |
View |
| 235 |
LARODX |
LAROTRECTINIB 25 MG |
CAPSULE |
BOTTLE |
TO TREAT A CERTAIN TYPE OF SOLID TUMORS IN ADULT, CHILDREN AND INFANT 4 WEEKS OF AGE AND OLDER THAT HAVE SPREAD TO PTHER PATRS OF THE BODY OR CANNOT BE TREATED SUCCESSFULLY WITH SURGERY |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
04 L 1087/24 |
08-APR-2024 |
07-APR-2027 |
View |
| 236 |
LENADX |
LENALIDOMIDE 10 MG |
CAPSULE |
BOTTLE |
TO TREAT A CERTAIN TYPE OF MYELODYSPLASTIC SYNDROME. |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
08 L 0999/23 |
16-AUG-2023 |
15-AUG-2026 |
View |
| 237 |
LENADX |
LENALIDOMIDE 25 MG |
CAPSULE |
BOTTLE |
TO TREAT A CERTAIN TYPE OF MYELODYSPLASTIC SYNDROME. |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
08 L 0998/23 |
16-AUG-2023 |
15-AUG-2026 |
View |
| 238 |
LENVIDX |
LENVATINIB 10 MG |
CAPSULE |
BOTTLE |
TREATMENT OF PATIENTS WITH LOCALLY RECURRENT OR METASTATIC, PROGRESSIVE, RADIOACTIVE IODINE-REFRACTORY DIFFERENTIATED THYROID CANCER |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
07 L 1156/24 |
07-AUG-2024 |
06-AUG-2027 |
View |
| 239 |
LENVIDX |
LENVATINIB 4 MG |
CAPSULE |
BOTTLE |
TREATMENT OF PATIENTS WITH LOCALLY RECURRENT OR METASTATIC, PROGRESSIVE, RADIOACTIVE IODINE-REFRACTORY DIFFERENTIATED THYROID CANCER |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
07 L 1155/24 |
07-AUG-2024 |
06-AUG-2027 |
View |
| 240 |
LETEDX |
LETERMOVIR 240 MG |
FILM COATED TABLET |
BOTTLE |
FOR PROPHYLAXIS OF CYTOMEGALOVIRUS INFECTION AND DISEASE IN ADULT CMV SEROPOSITIVE RECIPIENT OF ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANT |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
08 L 1172/24 |
22-AUG-2024 |
21-AUG-2027 |
View |
